HUP9903097A2 - Medicament containing progestogen-anti-progestogen - Google Patents

Medicament containing progestogen-anti-progestogen

Info

Publication number
HUP9903097A2
HUP9903097A2 HU9903097A HUP9903097A HUP9903097A2 HU P9903097 A2 HUP9903097 A2 HU P9903097A2 HU 9903097 A HU9903097 A HU 9903097A HU P9903097 A HUP9903097 A HU P9903097A HU P9903097 A2 HUP9903097 A2 HU P9903097A2
Authority
HU
Hungary
Prior art keywords
progestogen
dosage units
medicament containing
oestrogen
hrt
Prior art date
Application number
HU9903097A
Other languages
Hungarian (hu)
Inventor
Herman Jan Tijmen Coelingh Bennink
Pieter M. Verbost
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Priority to HU9903097A priority Critical patent/HUP9903097A3/en
Publication of HUP9903097A2 publication Critical patent/HUP9903097A2/en
Publication of HUP9903097A3 publication Critical patent/HUP9903097A3/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Contraceptive and/or hormone replacement therapy (HRT) kit comprises sequential daily dosage units comprising either: (a) a progestogen as contraceptive; or (b) a progestogen and/or an oestrogen as HRT, and two dosage units comprising an anti-progestogen. Also claimed is the use of daily dosage units in drug delivery systems comprising progestogen and/or oestrogen, and 2-7 dosage units anti-progestogen, one administered at the beginning and the remainder regularly divided throughout the cycle.
HU9903097A 1997-06-23 1997-06-23 Medicament containing progestogen-anti-progestogen HUP9903097A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9903097A HUP9903097A3 (en) 1997-06-23 1997-06-23 Medicament containing progestogen-anti-progestogen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9903097A HUP9903097A3 (en) 1997-06-23 1997-06-23 Medicament containing progestogen-anti-progestogen

Publications (2)

Publication Number Publication Date
HUP9903097A2 true HUP9903097A2 (en) 2000-01-28
HUP9903097A3 HUP9903097A3 (en) 2000-02-28

Family

ID=89999311

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903097A HUP9903097A3 (en) 1997-06-23 1997-06-23 Medicament containing progestogen-anti-progestogen

Country Status (1)

Country Link
HU (1) HUP9903097A3 (en)

Also Published As

Publication number Publication date
HUP9903097A3 (en) 2000-02-28

Similar Documents

Publication Publication Date Title
BR9709934A (en) Hormone replacement therapy kit and / or contraceptive use of daily dosage units consisting essentially of a progestogen and process of preparing a drug delivery system
MY124695A (en) Novel composition and use.
ZA897977B (en) Contraception system and method
UA41401C2 (en) Pharmaceutical combined contraceptive agent
MX9802370A (en) HORMONE REPLACEMENT THERAPY METHOD AND HORMONE DISPENSER Varying the daily dose of either or both of the estrogen and the progestogen administered for hormone replacement therapy (HRT) is readily and inexpensively accomplished, without the necessity
MX9804395A (en) Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen.
HRP20070188B1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
ATE239483T1 (en) PHARMACEUTICAL COMBINATION PREPARATION, KIT AND METHOD FOR HORMONAL CONTRACEPTION
NZ591627A (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
IL133762A0 (en) Transdermal therapeutic system (tts) for the administration of levonorgestral
AP1901A (en) Pharmaceutical composition for modified release insulin sensitiser.
MY117307A (en) New harmone medicaments and their use for correction of oestrogen deficiencies.
NZ332105A (en) Medicaments including human growth hormone for the treatment of type II diabetes and metabolic syndrome
HUP9903097A2 (en) Medicament containing progestogen-anti-progestogen
AU2691197A (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
ES1010439U (en) Single dose disposable dispenser for vaginal creams and the like. (Machine-translation by Google Translate, not legally binding)
MX9707009A (en) Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women.
TH55261B (en) The use of biogenic estrogen sulfamate in hormone replacement therapy.
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive
MX9705324A (en) Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts.